Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Applied Digital Corporation (APLD) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Applied Digital CorporationTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Applied Digital Corporation vs Citius Pharmaceuticals Inc — how do they compare? Applied Digital Corporation trades at $32.11 (market cap $8.55B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Applied Digital Corporation is far larger — about 427.3× Citius Pharmaceuticals Inc's market cap, and Applied Digital Corporation is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

APLDCTXR
Market Cap
$8.55B$20.01M
Sector
TechnologyHealth
52-Week High
$49.65$1.82
52-Week Low
$13.89$0.48
Enterprise Value
$12.06B$16.23M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Applied Digital Corporation

Applied Digital (APLD) trades at $29.06, down 0.55% on the day, with a bearish technical signal and recent earnings misses. The company reported a net loss of $231.07 million in 2025 despite revenue growth, while analyst consensus remains strongly bullish with a $72.36 price target. Recent news highlights significant AI infrastructure contracts and insider selling activity.

Outlook hinges on execution of its $36 billion AI infrastructure pipeline, but risks include high cash burn, negative margins, and rising debt. The stock offers high growth potential if operational targets are met, yet financial sustainability concerns warrant caution for investors amid volatile sentiment.

Citius Pharmaceuticals Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Applied Digital Corporation

Applied Digital provides high-performance computing (HPC) infrastructure and cloud services. It designs and operates data centers tailored for AI, machine learning, and other intensive digital workloads across North America.

Read more on APLD

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR